202 related articles for article (PubMed ID: 31825539)
21. The HAALT Non-invasive Scoring System for NAFLD in Obesity.
Sheth H; Bagasrawala S; Shah M; Ansari R; Olithselvan A; Lakdawala M
Obes Surg; 2019 Aug; 29(8):2562-2570. PubMed ID: 31016455
[TBL] [Abstract][Full Text] [Related]
22. Insulin Resistance Is Central to Long-Term Reversal of Histologic Nonalcoholic Steatohepatitis After Metabolic Surgery.
Russo MF; Lembo E; Mari A; Angelini G; Verrastro O; Nanni G; Pompili M; Raffaelli M; Vecchio FM; Bornstein SR; Mingrone G
J Clin Endocrinol Metab; 2021 Mar; 106(3):750-761. PubMed ID: 33248441
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
[TBL] [Abstract][Full Text] [Related]
24. Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.
Kazankov K; Tordjman J; Møller HJ; Vilstrup H; Poitou C; Bedossa P; Bouillot JL; Clement K; Grønbaek H
J Gastroenterol Hepatol; 2015 Aug; 30(8):1293-300. PubMed ID: 25772748
[TBL] [Abstract][Full Text] [Related]
25. An assessment of bacterial overgrowth and translocation in the non-alcoholic fatty liver of patients with morbid obesity.
Domper Bardají F; Gil Rendo A; Illescas Fernández-Bermejo S; Patón Arenas R; Hernández Albújar A; Martín Dávila F; Murillo Lázaro C; Sánchez Alonso M; Serrano Dueñas M; Sobrino López A; Ramírez Esteso F; Martín Fernández J
Rev Esp Enferm Dig; 2019 Apr; 111(4):294-300. PubMed ID: 30896956
[TBL] [Abstract][Full Text] [Related]
26. Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients.
D'Incao RB; Tovo CV; Mattevi VS; Borges DO; Ulbrich JM; Coral GP; Ramos MJ; Meinhardt NG
Obes Surg; 2017 Aug; 27(8):2151-2158. PubMed ID: 28281237
[TBL] [Abstract][Full Text] [Related]
27. The Effect of Non-Alcoholic Fatty Liver Disease on Weight Loss and Resolution of Obesity-Related Disorders After Bariatric Surgery.
Abdalla TSA; Giannou AD; Abdalla ASA; Izbicki JR; Dupreé A; Mann O; Wolter S
World J Surg; 2023 Dec; 47(12):3281-3288. PubMed ID: 37747548
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and outcome of non-alcoholic fatty liver disease in adolescents and young adults undergoing weight loss surgery.
Corey KE; Stanley TL; Misdraji J; Scirica C; Pratt J; Hoppin A; Misra M
Pediatr Obes; 2014 Oct; 9(5):e91-3. PubMed ID: 24677740
[TBL] [Abstract][Full Text] [Related]
29. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
Tai CM; Huang CK; Tu HP; Hwang JC; Chang CY; Yu ML
Surg Obes Relat Dis; 2015; 11(4):888-94. PubMed ID: 25240529
[TBL] [Abstract][Full Text] [Related]
30. Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome.
Kargiotis K; Athyros VG; Giouleme O; Katsiki N; Katsiki E; Anagnostis P; Boutari C; Doumas M; Karagiannis A; Mikhailidis DP
World J Gastroenterol; 2015 Jul; 21(25):7860-8. PubMed ID: 26167086
[TBL] [Abstract][Full Text] [Related]
31. Ketone body production is differentially altered in steatosis and non-alcoholic steatohepatitis in obese humans.
Männistö VT; Simonen M; Hyysalo J; Soininen P; Kangas AJ; Kaminska D; Matte AK; Venesmaa S; Käkelä P; Kärjä V; Arola J; Gylling H; Cederberg H; Kuusisto J; Laakso M; Yki-Järvinen H; Ala-Korpela M; Pihlajamäki J
Liver Int; 2015 Jul; 35(7):1853-61. PubMed ID: 25533197
[TBL] [Abstract][Full Text] [Related]
32. Evolution of Non-alcoholic Fatty Liver Disease (NAFLD) Biomarkers in Response to Weight Loss 1 Year After Bariatric Surgery-a Post Hoc Analysis of the FibroTest Prospective Study.
Codjia T; Rebibo L; François A; Lagnel C; Huet E; Bekri S; Pattou F; Régimbeau JM; Schwarz L
Obes Surg; 2021 Aug; 31(8):3548-3556. PubMed ID: 33844174
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and predictors of non-alcoholic steatohepatitis in patients with morbid obesity.
Meneses D; Olveira A; Corripio R; Méndez MDC; Romero M; Calvo-Viñuelas I; Herranz L; Vicent D; de-Cos-Blanco AI
Endocrinol Diabetes Nutr (Engl Ed); 2022 Mar; 69(3):178-188. PubMed ID: 35396116
[TBL] [Abstract][Full Text] [Related]
34. Body mass index and the visceral adipose tissue expression of IL-6 and TNF-alpha are associated with the morphological severity of non-alcoholic fatty liver disease in individuals with class III obesity.
Jorge ASB; Andrade JMO; Paraíso AF; Jorge GCB; Silveira CM; de Souza LR; Santos EP; Guimaraes ALS; Santos SHS; De-Paula AMB
Obes Res Clin Pract; 2018; 12(Suppl 2):1-8. PubMed ID: 27083404
[TBL] [Abstract][Full Text] [Related]
35. Hepatic expression of Yin Yang 1 (YY1) is associated with the non-alcoholic fatty liver disease (NAFLD) progression in patients undergoing bariatric surgery.
Yuan X; Chen J; Cheng Q; Zhao Y; Zhang P; Shao X; Bi Y; Shi X; Ding Y; Sun X; Xue B
BMC Gastroenterol; 2018 Oct; 18(1):147. PubMed ID: 30285651
[TBL] [Abstract][Full Text] [Related]
36. Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis.
Koliaki C; Szendroedi J; Kaul K; Jelenik T; Nowotny P; Jankowiak F; Herder C; Carstensen M; Krausch M; Knoefel WT; Schlensak M; Roden M
Cell Metab; 2015 May; 21(5):739-46. PubMed ID: 25955209
[TBL] [Abstract][Full Text] [Related]
37. Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery.
Pirvulescu I; Gheorghe L; Csiki I; Becheanu G; Dumbravă M; Fica S; Martin S; Sarbu A; Gheorghe C; Diculescu M; Copăescu C
Chirurgia (Bucur); 2012; 107(6):772-9. PubMed ID: 23294957
[TBL] [Abstract][Full Text] [Related]
38. Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study.
Ooi GJ; Burton PR; Bayliss J; Raajendiran A; Earnest A; Laurie C; Kemp WW; McLean CA; Roberts SK; Watt MJ; Brown WA
Obes Surg; 2019 Jan; 29(1):99-108. PubMed ID: 30229460
[TBL] [Abstract][Full Text] [Related]
39. Systematic review of bariatric surgery liver biopsies clarifies the natural history of liver disease in patients with severe obesity.
Bedossa P; Tordjman J; Aron-Wisnewsky J; Poitou C; Oppert JM; Torcivia A; Bouillot JL; Paradis V; Ratziu V; Clément K
Gut; 2017 Sep; 66(9):1688-1696. PubMed ID: 27884920
[TBL] [Abstract][Full Text] [Related]
40. Circulating lipidomic alterations in obese and non-obese subjects with non-alcoholic fatty liver disease.
Jung Y; Lee MK; Puri P; Koo BK; Joo SK; Jang SY; Lee DH; Jung YJ; Kim BG; Lee KL; Park TS; Kang KT; Ryu DH; Kang SW; Kim D; Oh S; Kim W; Hwang GS
Aliment Pharmacol Ther; 2020 Nov; 52(10):1603-1614. PubMed ID: 32892365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
